Relevance to NICE guidance programmes
The use of the Peptest is not currently planned into any NICE guidance programme.
NICE has issued the following guidance:
-
Dyspepsia and gastro-oesophageal reflux disease: Investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal reflux disease, or both. NICE guideline CG184 (2014). Date for review: September 2016.
-
NICE guideline on gastro-oesophageal reflux (GOR) in children. NICE guideline NG1 (2015)
-
Referral guidelines for suspected cancer. NICE guideline CG27 (June 2005, last modified April 2011).